We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10.52%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$15.6B
AUM Growth
+$1.35B
Cap. Flow
+$272M
Cap. Flow %
1.74%
Top 10 Hldgs %
17.46%
Holding
2,121
New
637
Increased
418
Reduced
436
Closed
588

Sector Composition

Rank Sector Weight
1 Healthcare 24.06%
2 Consumer Discretionary 14.39%
3 Financials 10.11%
4 Technology 9.6%
5 Industrials 7.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WB icon
726
Weibo
WB
$1.92B
$2.64M 0.02%
+72,526
New +$2.56M
TROX icon
727
Tronox
TROX
$973M
$2.64M 0.02%
335,221
-185,056
-36% -$1.54M
PLYM
728
DELISTED
Plymouth Industrial REIT
PLYM
$2.63M 0.02%
212,834
+184,249
+645% +$2.41M
SBSW icon
729
Sibanye-Stillwater
SBSW
$6.05B
$2.62M 0.02%
234,749
+219,221
+1,412% +$2.5M
SKY icon
730
Champion Homes
SKY
$4.52B
$2.62M 0.02%
97,683
-3,126
-3% -$85.2K
FIIIU
731
DELISTED
Forum Merger III Corporation Units
FIIIU
$2.61M 0.02%
+250,000
New +$2.55M
KCAC.U
732
DELISTED
Kensington Capital Acquisition Corp.Units, each consisting of one share of Class A common stock and
KCAC.U
$2.61M 0.02%
137,500
-137,500
-50% -$1.83M
CANO
733
DELISTED
Cano Health, Inc.
CANO
$2.6M 0.02%
+2,500
New +$2.61M
IMKTA icon
734
Ingles Markets
IMKTA
$1.67B
$2.6M 0.02%
68,207
+22,184
+48% +$893K
SNDR icon
735
Schneider National
SNDR
$6.44B
$2.59M 0.02%
+104,900
New +$2.71M
TOI icon
736
The Oncology Institute
TOI
$519M
$2.59M 0.02%
+249,968
New +$2.6M
WPF
737
DELISTED
Foley Trasimene Acquisition Corp.
WPF
$2.59M 0.02%
+249,981
New +$2.58M
PBCT
738
DELISTED
People's United Financial Inc
PBCT
$2.59M 0.02%
250,971
-49,535
-16% -$538K
MTD icon
739
Mettler-Toledo International
MTD
$27B
$2.57M 0.02%
2,665
-10,881
-80% -$10.1M
DHI icon
740
D.R. Horton
DHI
$41.3B
$2.56M 0.02%
33,913
-287,892
-89% -$19.7M
NYT icon
741
New York Times
NYT
$11.7B
$2.56M 0.02%
59,944
-122,160
-67% -$5.35M
TPB icon
742
Turning Point Brands
TPB
$1.52B
$2.56M 0.02%
91,740
-21,496
-19% -$632K
LTRPA
743
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$2.56M 0.02%
1,478,064
TV icon
744
Televisa
TV
$1.48B
$2.55M 0.02%
413,260
+97,795
+31% +$596K
NBL
745
DELISTED
Noble Energy, Inc.
NBL
$2.55M 0.02%
298,577
+203,653
+215% +$1.99M
CPSR.U
746
DELISTED
Capstar Special Purpose Acquisition Corp. Units, each consisting of one share of Class A Common Stoc
CPSR.U
$2.55M 0.02%
+250,000
New +$2.55M
RNAC icon
747
Cartesian Therapeutics
RNAC
$229M
$2.54M 0.02%
+34,102
New +$2.61M
TAC icon
748
TransAlta
TAC
$4.25B
$2.54M 0.02%
413,810
-394,331
-49% -$2.47M
FMX icon
749
Fomento Económico Mexicano
FMX
$45B
$2.5M 0.02%
44,429
-62,092
-58% -$3.62M
SPXC icon
750
SPX Corp
SPXC
$11B
$2.49M 0.02%
53,779
-24,745
-32% -$1.04M

Similar funds

Marshall Wace's Q3 2020 Portfolio in Review

As of Q3 2020, Marshall Wace held 2,121 positions worth $15.6B, up 9.5% from $14.3B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Marshall Wace's Q3 2020 filing shows 637 new, 418 increased, 436 reduced and 588 closed positions. Its largest new stake was Keurig Dr Pepper: 2,859,399 shares worth $78.9M. The largest sale was Alibaba, an estimated $170M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Marshall Wace's largest Q3 2020 buy was Keurig Dr Pepper: 2,859,399 shares worth $78.9M.
  • Marshall Wace added most to Alphabet (Google) Class A in Q3 2020, an estimated $208M increase.
  • Marshall Wace's biggest Q3 2020 reduction was Alibaba, cutting an estimated $170M.
  • Marshall Wace fully exited Procter & Gamble in Q3 2020, selling an estimated $139M.
  • Marshall Wace's ten largest holdings make up 17% of its $15.6B portfolio in Q3 2020.
  • Marshall Wace opened 637 new positions and closed 588 in Q3 2020.
  • Marshall Wace's portfolio value rose 9.5% quarter-over-quarter to $15.6B.

Based on Marshall Wace's 13F filing for Q3 2020, filed 16 Nov 2020.